title: Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.
authors.forename: Andrés
authors.initials: A
authors.lastname: Herrán
authors.forename: Maria L
authors.initials: ML
authors.lastname: Ramírez
authors.forename: Maria
authors.initials: M
authors.lastname: Carrera
authors.forename: Maria T
authors.initials: MT
authors.lastname: García-Unzueta
authors.forename: Deirdre
authors.initials: D
authors.lastname: Sierra-Biddle
authors.forename: Beatriz
authors.initials: B
authors.lastname: Rodríguez-Cabo
authors.forename: Ana
authors.initials: A
authors.lastname: Ayestarán
authors.forename: Fernando
authors.initials: F
authors.lastname: Hoyuela
authors.forename: Jose L
authors.initials: JL
authors.lastname: Vázquez-Barquero
mesh_terms: D000328:Adult; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015283:Citalopram / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016584:Panic Disorder / Q000097:blood / Q000188:drug therapy*; D017374:Paroxetine / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D012044:Regression Analysis; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D002784:Cholesterol; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015283:Citalopram; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline